Audentes Therapeutics (BOLD) News Today → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free BOLD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsHeadlinesInsider TradesSocial MediaStock AnalysisAnalyst ForecastsHeadlinesInsider TradesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 7:00 AM | businesswire.comBoundless Bio Reports First Quarter 2024 Financial Results and Corporate HighlightsMay 6, 2024 | businesswire.comBoundless Bio to Present at the Citizens JMP Life Sciences Conference 2024April 30, 2024 | finance.yahoo.comMalignant Ascites Market to Observe Growth at a CAGR of 1.2% by 2034 | DelveInsightApril 26, 2024 | seekingalpha.comBOLD Boundless Bio, Inc.April 11, 2024 | bbc.co.ukBold GirlsApril 11, 2024 | businesswire.comBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene AmplificationsApril 11, 2024 | morningstar.comBoundless Bio Inc BOLDApril 8, 2024 | businesswire.comBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024March 27, 2024 | businesswire.comBoundless Bio Announces Pricing of Initial Public OfferingNovember 25, 2023 | cnn.comMarriott Bonvoy Bold credit card review 2023November 4, 2023 | yahoo.comKristen Louelle Is Bold and Beautiful in These 4 Pics in Atlantic CityOctober 27, 2023 | usatoday.comWhat Top 25 upsets are coming this weekend? Bold predictions for Week 5 in college footballApril 27, 2023 | forbes.comHow Bold Leadership Can Help Or Hurt YouApril 23, 2023 | finance.yahoo.comBold Therapeutics Presents Jaw-Dropping Interim Phase 2 Clinical Data for BOLD-100 in the Treatment of Advanced Colorectal Cancer at AACR 2023April 18, 2023 | entrepreneur.comThe Benefits of Bold Leadership and How Leaders Can Develop a Bold MindsetApril 2, 2023 | usatoday.comFive bold predictions for the men's NCAA Tournament's Final FourMarch 26, 2023 | usatoday.comMen's NCAA Tournament 2023: 10 bold predictions for March MadnessMarch 23, 2023 | finance.yahoo.com5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough ScienceMarch 17, 2023 | forbes.comTikTok Has A New ‘Bold Glamour’ AI-Powered Filter, Here Are The RisksMarch 12, 2023 | yahoo.comYou but better? Not so fast. Unpacking TikTok's controversial 'Bold Glamour' filterJanuary 18, 2023 | news.yahoo.comOn King's holiday, daughter calls for bold action over wordsJanuary 17, 2023 | dailymail.co.ukIt's blue Monday... Let's embrace it says JO ELVIN, with this season's refreshingly bold take on the colourJanuary 13, 2023 | forbes.comPersonal And Career Success One Bold Move A DayJanuary 5, 2023 | theguardian.comLeBron exits LA and an American F1 star: our bold sports predictions for 2023November 14, 2022 | usatoday.comBold predictions for college football's Week 11 have Alabama and LSU on upset alertOctober 8, 2022 | nypost.comLEGO makes bold claim on how bricks affect mental healthAugust 24, 2022 | investing.comBOLD_old Historical DataAugust 22, 2022 | yahoo.comFDA approves first fast-acting oral drug for clinical depressionMarch 18, 2022 | yahoo.comAppnovation Earns Seven 2022 MUSE Creative AwardsSeptember 16, 2021 | finance.yahoo.comNemours Children's Health Officially Launches New Brand to Advance Children's HealthSeptember 14, 2021 | feeds.benzinga.comAstellas' Gene Therapy Trial Hit With Another Death, FDA Slaps Clinical Hold Get Audentes Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it. This means you must act NOW before it's too late. BOLD Media Mentions By Week BOLD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BOLD News Sentiment▼0.000.55▲Average Medical News Sentiment BOLD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BOLD Articles This Week▼40▲BOLD Articles Average Week Get Audentes Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Butterfly Network News Today Trevi Therapeutics News Today INmune Bio News Today Century Therapeutics News Today Conduit Pharmaceuticals News Today Inogen News Today Opthea News Today Kodiak Sciences News Today P3 Health Partners News Today Zevra Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BOLD) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDoes this make you sick?Allegiance Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Audentes Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
